✦ LIBER ✦

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

✍ Scribed by Gheath Alatrash; Marcos de Lima; Nelson Hamerschlak; Matteo Pelosini; Xuemei Wang; Lianchun Xiao; Fabio Kerbauy; Alexandre Chiattone; Gabriela Rondon; Muzaffar H. Qazilbash; Sergio A. Giralt; Leandro de Padua Silva; Chitra Hosing; Partow Kebriaei; Weiqing Zhang; Yago Nieto; Rima M. Saliba; Richard E. Champlin; Borje S. Andersson

Book ID: 116282639
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 360 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.02.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen

✍ G. Alatrash; B. Andersson; M. Pelosini; G. Rondon; M. Qazilbash; S. Giralt; L. d 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Reduced-toxicity conditioning with treos

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)

✍ Kröger, N; Shimoni, A; Zabelina, T; Schieder, H; Panse, J; Ayuk, F; Wolschke, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB